𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity

✍ Scribed by L. T. Kopeikina; E. F. Kamper; V. Koutsoukos; Y. Bassiakos; I. Stavridis

Publisher
Springer
Year
1997
Tongue
English
Weight
812 KB
Volume
16
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Complex of urokinase-type plasminogen ac
Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node–negative breast carcinoma
✍ Peggy Manders; Vivianne C. G. Tjan-Heijnen; Paul N. Span; Nicolai Grebenchtchiko πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 1 views

## Background: The ability of a solid tumor to grow and metastasize has a significant dependence on protease systems, such as the plasminogen activation system. the plasminogen activation system includes the urokinase-type plasminogen activator (upa) and plasminogen activator inhibitor type 1 (pai-

Elevation of serum levels of urokinase-t
Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer
✍ Miyake, Hideaki; Hara, Isao; Yamanaka, Kazuki; Gohji, Kazuo; Arakawa, Soichi; Ka πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 175 KB πŸ‘ 1 views

BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a